Erchonia Medical has announced that their model Erchonia Neira 4L low-level laser is the first device of its kind to receive approval for use during liposuction by the U.S. Food and Drug Administration (FDA).
The approval represents a significant breakthrough in the liposuction procedure since it gives surgeons a proven, safe method for reducing post-operative pain and shortening recovery time.
When treatment is administered just prior to surgery, the painless, non- invasive Erchonia laser facilitates the removal of fatty tissue, thus reducing trauma during the procedure. As a result, liposuction is made quicker, easier and less painful.
Overwhelmingly positive results from a multi-center, double-blind, randomized study approved by the International Review Board led to FDA approval of the Erchonia Neira 4L laser. The study compared placebo- treated liposuction patients to those treated with an active laser. Actively- treated patients demonstrated considerably less pain than the placebo group.